The Growing Importance of the Employee Experience
-
By
-
Debbie Bunch
-
June 18, 2026
-
0 min
By
Debbie Bunch
June 18, 2026
Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.
June 16, 2026
Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.
June 18, 2026